Recent advances in technologies for developing drugs againstChlamydia pneumoniae
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery
Link
http://www.tandfonline.com/doi/pdf/10.1517/17460441.2014.915309
Reference89 articles.
1. Endovascular Presence of Viable Chlamydia pneumoniaeIs a Common Phenomenon in Coronary Artery Disease 11This study was supported in part by the Research Commission of the Medical University of Lübeck (8/96) and the Deutsche Forschungsgemeinschaft (SFB 367/B2), Bonn, Germany.
2. Effects of Antibiotic Therapy on Outcomes of Patients With Coronary Artery Disease
3. Infection, Antibiotics, and Atherothrombosis — End of the Road or New Beginnings?
4. Pathogens and atherosclerosis: Update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tracking Chlamydia – Host interactions and antichlamydial activity in Caenorhabditis elegans;Biomedicine & Pharmacotherapy;2024-08
2. Assaying Chlamydia pneumoniae Persistence in Monocyte-Derived Macrophages Identifies Dibenzocyclooctadiene Lignans as Phenotypic Switchers;Molecules;2020-01-11
3. Current Research of Chlamydial Infection Diseases in China;Chinese Medical Journal;2018-02-20
4. Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy;Journal of Natural Products;2017-10-18
5. Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors;Microorganisms;2016-11-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3